RhumbLine Advisers’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.6M Buy
404,660
+22,806
+6% +$821K 0.01% 883
2025
Q1
$15.1M Sell
381,854
-1,259
-0.3% -$49.6K 0.01% 838
2024
Q4
$11.5M Buy
383,113
+504
+0.1% +$15.2K 0.01% 987
2024
Q3
$8.95M Buy
382,609
+167,554
+78% +$3.92M 0.01% 1120
2024
Q2
$3.83M Buy
215,055
+15,582
+8% +$277K ﹤0.01% 1532
2024
Q1
$3.03M Buy
199,473
+5,995
+3% +$91.2K ﹤0.01% 1684
2023
Q4
$3.3M Buy
193,478
+4,272
+2% +$73K ﹤0.01% 1647
2023
Q3
$1.58M Sell
189,206
-254
-0.1% -$2.12K ﹤0.01% 1972
2023
Q2
$4.71M Buy
189,460
+10,040
+6% +$249K 0.01% 1415
2023
Q1
$2.7M Buy
179,420
+8,117
+5% +$122K ﹤0.01% 1654
2022
Q4
$2.03M Buy
171,303
+8,772
+5% +$104K ﹤0.01% 1782
2022
Q3
$962K Buy
162,531
+11,044
+7% +$65.4K ﹤0.01% 2154
2022
Q2
$644K Buy
151,487
+19,449
+15% +$82.7K ﹤0.01% 2355
2022
Q1
$1.26M Buy
132,038
+553
+0.4% +$5.26K ﹤0.01% 2037
2021
Q4
$2.5M Sell
131,485
-1,460
-1% -$27.7K ﹤0.01% 1755
2021
Q3
$4.42M Buy
132,945
+2,222
+2% +$73.9K 0.01% 1428
2021
Q2
$5.07M Sell
130,723
-13,339
-9% -$517K 0.01% 1422
2021
Q1
$6.94M Sell
144,062
-3,679
-2% -$177K 0.01% 1217
2020
Q4
$7.69M Buy
147,741
+16,621
+13% +$865K 0.01% 1094
2020
Q3
$3.51M Sell
131,120
-17,230
-12% -$461K 0.01% 1374
2020
Q2
$2.89M Buy
148,350
+29,907
+25% +$583K ﹤0.01% 1514
2020
Q1
$1.17M Buy
118,443
+16,819
+17% +$165K ﹤0.01% 1810
2019
Q4
$1.13M Buy
101,624
+5,945
+6% +$66K ﹤0.01% 2025
2019
Q3
$537K Buy
95,679
+1,976
+2% +$11.1K ﹤0.01% 2289
2019
Q2
$811K Buy
93,703
+15,990
+21% +$138K ﹤0.01% 2151
2019
Q1
$625K Sell
77,713
-1,185
-2% -$9.53K ﹤0.01% 2233
2018
Q4
$323K Buy
78,898
+26,880
+52% +$110K ﹤0.01% 2506
2018
Q3
$291K Sell
52,018
-2,569
-5% -$14.4K ﹤0.01% 2527
2018
Q2
$718K Buy
54,587
+8,435
+18% +$111K ﹤0.01% 2152
2018
Q1
$655K Buy
46,152
+1,480
+3% +$21K ﹤0.01% 2108
2017
Q4
$366K Sell
44,672
-8,620
-16% -$70.6K ﹤0.01% 2369
2017
Q3
$632K Buy
53,292
+690
+1% +$8.18K ﹤0.01% 2202
2017
Q2
$529K Buy
52,602
+10,585
+25% +$106K ﹤0.01% 2262
2017
Q1
$489K Buy
42,017
+1,468
+4% +$17.1K ﹤0.01% 2260
2016
Q4
$189K Buy
40,549
+2,812
+7% +$13.1K ﹤0.01% 2686
2016
Q3
$292K Buy
37,737
+190
+0.5% +$1.47K ﹤0.01% 2500
2016
Q2
$228K Buy
37,547
+3,107
+9% +$18.9K ﹤0.01% 2675
2016
Q1
$293K Buy
34,440
+40
+0.1% +$340 ﹤0.01% 2538
2015
Q4
$410K Buy
34,400
+2,395
+7% +$28.5K ﹤0.01% 2377
2015
Q3
$323K Sell
32,005
-489
-2% -$4.94K ﹤0.01% 2490
2015
Q2
$539K Buy
32,494
+5,840
+22% +$96.9K ﹤0.01% 2276
2015
Q1
$413K Buy
26,654
+6,195
+30% +$96K ﹤0.01% 2415
2014
Q4
$324K Buy
20,459
+1,545
+8% +$24.5K ﹤0.01% 2538
2014
Q3
$202K Buy
18,914
+200
+1% +$2.14K ﹤0.01% 2746
2014
Q2
$176K Buy
18,714
+8,088
+76% +$76.1K ﹤0.01% 2879
2014
Q1
$73K Sell
10,626
-620
-6% -$4.26K ﹤0.01% 2949
2013
Q4
$44K Sell
11,246
-300
-3% -$1.17K ﹤0.01% 3002
2013
Q3
$59K Buy
11,546
+376
+3% +$1.92K ﹤0.01% 2963
2013
Q2
$71K Buy
+11,170
New +$71K ﹤0.01% 3280